International Journal of Dentistry / 2014 / Article / Tab 3 / Clinical Study
New Dimensional Staging of Bisphosphonate-Related Osteonecrosis of the Jaw Allowing a Guided Surgical Treatment Protocol: Long-Term Follow-Up of 266 Lesions in Neoplastic and Osteoporotic Patients from the University of Bari Table 3 Patients clinical data (
).
% Patients characteristics Males 50 24.63% Females 153 75.37% Mean age
Neoplastic patients 145 71.43% Breast cancer 58 40% Multiple myeloma 42 28.97% Prostate cancer 20 13.79% Lung cancer 5 3.45% Others 20 13.79% Osteoporotic patients 58 28.57% Type of BPs treatment Oral administration 46 22.66% Parenteral administration 157 77.34% Neoplastic patients Zoledronic acid 137 94.48% Clodronate 4 2.76% Risedronate 3 2.07% Pamidronate 1 0.7% Mean duration therapy
months Osteoporotic patients Alendronate 30 51.72% Clodronate 8 13.79% Ibandronate 5 8.62% Zoledronic acid 4 6.9% Risedronate 4 6.9% Off-label therapy 7 12.1% Mean duration therapy
months
